{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicqp7at3sj4tni3veap6oxuxjyzago5sbq2kolnmti3mbppoqvqjy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3moyh6dxj62d2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic63j54mjdowavwsbba754cqzmzgcem5plw46pmb3fngpyoi7matq"
    },
    "mimeType": "image/jpeg",
    "size": 287883
  },
  "path": "/news/2026-06-dose-malaria-treatment-advances-pan.html",
  "publishedAt": "2026-06-23T17:40:08.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients. The four-drug combination treatment, known as SPAP, is now being prepared for large-scale clinical testing across Africa. Prof. Ghyslain Mombo-Ngoma, who was named to the 2026 TIME100 Health list in recognition of his contributions to global health research, is co-leading the project.",
  "title": "Promising single-dose malaria treatment advances toward pan-African clinical trial"
}